1. |
Chen X, Varki A. Advances in the biology and chemistry of sialic acids. ACS Chem Biol, 2010, 5(2): 163-176.
|
2. |
Bhide GP, Colley KJ. Sialylation of N-glycans: mechanism, cellular compartmentalization and function. Histochem Cell Biol, 2017, 147(2): 149-174.
|
3. |
Vajaria BN, Patel PS. Glycosylation: a hallmark of cancer? Glycoconj J, 2017, 34(2): 147-156.
|
4. |
Vajaria BN, Patel KR, Begum R, et al. Sialylation: an avenue to target cancer cells. Pathol Oncol Res, 2016, 22(3): 443-447.
|
5. |
Li Y, Chen X. Sialic acid metabolism and sialyltransferases: natural functions and applications. Appl Microbiol Biotechnol, 2012, 94(4): 887-905.
|
6. |
Monti E, Miyagi T. Structure and function of mammalian sialidases. Top Curr Chem, 2015, 366: 183-208.
|
7. |
Miyagi T, Yamaguchi K. Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology, 2012, 22(7): 880-896.
|
8. |
Miyagi T, Wada T, Yamaguchi K, et al. Plasma membrane-associated sialidase as a crucial regulator of transmembrane signalling. J Biochem, 2008, 144(3): 279-285.
|
9. |
Miyagi T, Takahashi K, Shiozaki K, et al. Plasma membrane-associated sialidase confers cancer initiation, promotion and progression. Adv Exp Med Biol, 2015, 842: 139-145.
|
10. |
Zheng C, Terreni M, Sollogoub M, et al. Ganglioside GM3 and its role in cancer. Curr Med Chem, 2018. [Epub ahead of print].
|
11. |
陈阳, 吴英良, 山形贞子, 等. 细胞质唾液酸酶 (Neu2) 通过 Cdk2 通路抑制 FBJ-LL 细胞生长. 沈阳药科大学学报, 2010,27(2): 147-151.
|
12. |
Sandhu R, Lal H, Kundu ZS, et al. Serum fluoride and sialic acid levels in osteosarcoma. Biol Trace Elem Res, 2011, 144(1-3): 1-5.
|
13. |
郭征. 我国骨肉瘤治疗的现状与问题及发展方向. 中国骨与关节杂志, 2015, 4(5): 338-342.
|
14. |
耿磊, 陈继营, 许猛, 等. 骨肉瘤的治疗进展. 中国矫形外科杂志, 2015, 23(21): 1975-1978.
|
15. |
Hata K, Tochigi T, Sato I, et al. Increased sialidase activity in serum of cancer patients: Identification of sialidase and inhibitor activities in human serum. Cancer science, 2015, 106(4): 383-389.
|
16. |
Miyagi T, Takahashi K, Hata K, et al. Sialidase significance for cancer progression. Glycoconj J, 2012, 29(8-9): 567-577.
|
17. |
Jacobsen A, Bosch LJW, Martens-de Kemp SR, et al. Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer. Sci Rep, 2018, 8(1): 7522.
|
18. |
Khan AQ, Kuttikrishnan S, Siveen KS, et al. RAS-mediated oncogenic signaling pathways in human malignancies. Semin Cancer Biol, 2018. [Epub ahead of print].
|
19. |
Campbell KJ, Tait SWG. Targeting BCL-2 regulated apoptosis in cancer. Open Biol, 2018, 2(8): 443-460.
|
20. |
Perini GF, Ribeiro GN, Pinto Neto JV, et al. BCL-2 as therapeutic target for hematological malignancies. J Hematol Oncol, 2018, 11(1): 65.
|